Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis

被引:56
作者
Harp, Christopher T. [1 ]
Lovett-Racke, Amy E. [2 ]
Racke, Michael K. [3 ]
Frohman, Elliot M. [1 ]
Monson, Nancy L. [1 ,4 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA
[2] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Med Ctr, Dept Neurol, Columbus, OH 43210 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA
关键词
autoimmunity; B cells; multiple sclerosis; antigen presentation;
D O I
10.1016/j.clim.2008.05.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The rote of B cells in the pathogenesis of Multiple Sclerosis (MS) is incompletely understood. Here we define a possible role for B cells as myelin-specific antigen presenting cells (B-APCs) in MS. Peripheral blood B cells (PBBC) isolated from both MS patients and healthy controls (HC) were activated in vitro with either CD40L/IL-4 or a Class B CpG oligodeoxynucleotide (CpG CDN)/IL-2. Both activation techniques induced PBBCs to upregulate CD80 and HLA-DR, rendering them more efficient APCs than resting 8 cells. Although the CD40L/IL-4 B-APCs were highly effective in eliciting CNS-antigen specific proliferation by autologous T-cells, CpG ODN/IL-2 stimulated B cells were not. Furthermore, CD40L/IL-4 B-APC induced responses by autologous CD4(+) T cells were susceptible to blocking with anti-HLA-DR antibody, suggesting that T cell responses were specific for antigen presentation by B-APC. CNS-antigen specific CD8(+) T cell proliferation was also blocked by HLA-DR, suggesting that CD8(+) proliferation is in part dependent on CD4(+) help. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:382 / 391
页数:10
相关论文
共 55 条
[1]   Quantitation of rare memory B cell populations by two independent and complementary approaches [J].
Amanna, Ian J. ;
Slifka, Mark K. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 317 (1-2) :175-185
[2]   Roles of immunoglobulins and B cells in multiple sclerosis: From pathogenesis to treatment [J].
Antel, Jack ;
Bar-Or, Amit .
JOURNAL OF NEUROIMMUNOLOGY, 2006, 180 (1-2) :3-8
[3]   A new clinically relevant approach to expand myelin specific T cells [J].
Arbour, N ;
Lapointe, R ;
Saikali, P ;
McCrea, E ;
Regen, T ;
Antel, JP .
JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 310 (1-2) :53-61
[4]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[5]   Immunological memory: Contribution of memory B cells expressing costimulatory molecules in the resting state [J].
Bar-Or, A ;
Oliveira, EML ;
Anderson, DE ;
Krieger, JI ;
Duddy, M ;
O'Connor, KC ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5669-5677
[6]  
Becher B, 2000, GLIA, V29, P293
[7]   Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145
[8]   Class II MHC peptide loading by the professionals [J].
Bryant, P ;
Ploegh, H .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :96-102
[9]   Primary T cell expansion and requires antigen presentation differentiation in vivo by B cells [J].
Crawford, Alison ;
MacLeod, Megan ;
Schumacher, Ton ;
Corlett, Louise ;
Gray, David .
JOURNAL OF IMMUNOLOGY, 2006, 176 (06) :3498-3506
[10]   Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients [J].
Cross, Anne H. ;
Stark, Jennifer L. ;
Lauber, Joanne ;
Ramsbottom, Michael J. ;
Lyons, Jeri-Anne .
JOURNAL OF NEUROIMMUNOLOGY, 2006, 180 (1-2) :63-70